Long term results of induction carboplatin (CBDCA) and docetaxel (DOC) with concurrent radiation in early-stage non-small cell lung cancer (NSCLC)

7237 Background: Despite surgical resection, patients with clinical T2N0, T1–2N1 and T3N0 NSCLC have poor 5-year survivals (30% to 50%). Since a significant proportion of patients with early-stage ...